Proposed transaction combines PRF’s DeepSolar/GridFeed™ renewable energy forecasting and storage optimization platform with Dotz’s AI-driven energy management technologies, creating an expanded offering across energy
Preliminary cash, including short-term deposits, of approximately $11.0 million as of September 30, 2026, and total liabilities of approximately $2.5 million Interim CEO Efraim Cohen-Arazi details LayerBio’s plans to
IEA projects global data center electricity consumption to roughly double to 950 TWh by 2030, with consumption from AI-focused data centers expected to triple Company believes GridFeed’s existing AI optimization engine
New structure designed to enable direct strategic investment, partnerships, and commercial collaborations GridFeed built on validated AI technology and commercial engagements with leading renewable energy companies
FDA cleared the IND for OcuRing™-K, enabling a U.S. multi-center Phase II trial in cataract surgery with patient enrollment expected in the second half of 2026 PRF-110 matched an approved, commercially available
TEL AVIV, Israel, July 27, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF", "PRF Technologies" or the "Company") today issued a Letter to Shareholders from Efraim
TEL AVIV, Israel, July 21, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today announced that its DeepSolar business unit will participate in Energy Trading Week
TEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today announced the expansion of DeepSolar Predict™, the Company’s AI-driven renewable
TEL AVIV, Israel, July 08, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today announced that its DeepSolar business unit has completed an initial validation
TEL AVIV, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company"), a clinical-stage specialty pharmaceutical company focused on reformulating established
TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today provided an update on the advancement of DeepSolar Predict™, the Company's AI-driven
TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company"), a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for
TEL AVIV, Israel, April 28, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company"), a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for
LayerBio's OcuRing™-K program and broader ocular platform strengthen PRF's healthcare growth strategy DeepSolar advances from acquisition to early commercial deployment TEL AVIV, Israel, March 27, 2026 (GLOBE
TEL AVIV, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today announced a commercial collaboration agreement with Blade Ranger Ltd. (TASE: BLRN) designed to
